NASDAQ: TGTX · Health Care / Biotechnology: Pharmaceutical Preparations

TG Therapeutics Inc.

How TG Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap
$8.9B
Price
$58.08
P/E
20.1
EPS (TTM)
$2.88
1-year return
71.9%
Dividend yield
0.0%
52-week range
$30.45–$58.08

Compared with

For information only, not investment advice. Data may contain errors. Disclaimer · Sources